Perioperative Cardiac Risk Assessment
Based on the original module, Perioperative Cardiac Risk Management, by Zishan Siddiqui, MD, and Leonard Feldman, MD, FACP, SFHM
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient with the option of surgery. To assess for the preoperative cardiac risk, hospitalists should follow a step-wise algorithm. The following module reviews the risk assessment process and enables the hospitalist to order appropriate preoperative testing.
Provide hospitalists with current assessment strategies to evaluate for perioperative cardiac risk.
This activity is designed for hospitalists. No prerequisites required.
After completing the module, the participant will demonstrate the ability to:
- Tailor the perioperative evaluation based on the urgency of the procedure.
- Determine if there are red flag issues that may necessitate delaying nonemergent surgery.
- Estimate the combined clinical/surgical risk based on validated models.
- Determine functional status using metabolic equivalents.
- Assess the appropriate uses for cardiac stress testing and coronary revascularization.
- Evaluate the role of perioperative biomarkers for cardiac risk assessment.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of University of Virginia School of Medicine, ASiM, and the Society of Hospital Medicine. The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Virginia School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: April 22, 2015. Expiration date: April 22, 2018
Estimated time to complete activity: 2 hours
FACULTY AND FACULTY DISCLOSURES
Full Disclosure Policy Affecting CME Activities:
The University of Virginia School of Medicine, as an ACCME accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices.
The University of Virginia School of Medicine requires that all CME activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
All faculty presenters participating in an accredited CME activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.). The University of Virginia School of Medicine will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine, Charlottesville, Virginia.
The faculty and staff of the University of Virginia Office of Continuing Medical Education have no financial affiliations to disclose.
The following relationships have been reported for this activity:
Leonard Feldman, MD (Chair)
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Med-Peds Urban Health Residency Program Director
Associate Program Director, Osler Medical Residency
Director, Comprehensive General Medicine Consult Service
Editor, Consultative, and Perioperative Medicine Essentials for Hospitalists
Dr Feldman reports having no significant financial or advisory relationships with corporate organizations related to this activity.
Steven L. Cohn, MD, FACP, SFHM
Medical Director – UHealth Preoperative Assessment Center
Director – Medical Consultation Service
Professor of Clinical Medicine
University of Miami Miller School of Medicine
Dr Cohn reports owning stock in AstraZeneca, GlaxoSmithKline, Merck & Co, Inc, and Pfizer Inc; and reports serving on the advisory committee/board for Bristol-Myers Squibb Company and Janssen.
Bartho Caponi, MD (Peer Reviewer)
Clinical Assistant Professor
Division of Hospital Medicine
University of Wisconsin Hospital and Clinics
Dr Caponi reports having no significant financial or advisory relationships with corporate
organizations related to this activity.
Off-Label Product Discussion:
All faculty have indicated that they have not referenced unlabeled or unapproved uses of drugs or devices.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Blackwell Futura Media Services name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Click here to download the references for this educational activity.
The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, a study program, and a CME post-test. All 3 sections must be completed to receive CME credit.
Steven L. Cohn, MD, FACP, SFHM
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Equivalent